Studies have found that HOXA-AS2 is able to inhibit endothelial inflammation via the nuclear factor kappa B (NF-κB) pathway and that lower expression of HOXA-AS2 in diabetic nephropathy is associated with kidney injury and inflammatory response [29, 30]. Here, HOXA-AS2 is linked to diabetic kidney disease.